APIs - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 13 Issue 4

Understanding the Challenges of Highly Potent Actives

A rising number of active pharmaceutical ingredients (APIs) are classed as “highly potent”. They are being increasingly harnessed by pharma companies developing oral...

24 November 2021 Volume 13 Issue 4 active pharmaceutical ingredients | APIs

Continue Reading →

Volume 13 Issue 3

Formulation and Process Considerations for Optimising Spray-Dried Solid Dispersions

Spray drying active pharmaceutical ingredients (APIs) in solution to overcome solubility hurdles requires part craft and great attention to process variables. Today’...

13 September 2021 Volume 13 Issue 3 APIs | drug innovators

Continue Reading →

News

Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers

Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients (APIs), and SPI Pharma, a global leader in the manuf...

24 April 2018 News agreement | APIs

Continue Reading →

News

Pharma set for prosperous 2018 as 44,500 attend CPhI Worldwide

CPhI Worldwide, organised by UBM, closes its 28th edition with pre-audit figures indicating a record-breaking attendance of over 44,500* and 2,598 exhibitors. Held i...